Article info
Editorial
Phenotypical variation in Alzheimer's disease: insights from posterior cortical atrophy
- Correspondence to Dr J M Schott, Dementia Research Centre, Institute of Neurology, UCL, London WC1N 3BG, UK; j.schott{at}ucl.ac.uk
Citation
Phenotypical variation in Alzheimer's disease: insights from posterior cortical atrophy
Publication history
- Accepted August 18, 2014
- First published September 19, 2014.
Online issue publication
January 22, 2015
Article Versions
- Previous version (19 September 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Hiding in plain sight: a closer look at posterior cortical atrophy
- Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease
- Amyloid PET imaging in clinical practice
- Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients
- Alzheimer's disease: mimics and chameleons
- The language profile of posterior cortical atrophy
- Dementia
- Down syndrome with posterior cortical atrophy
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias